Astragalus has more kidney research than almost any other herb, and 2 facts change how it should be read. Most of the 66 trials used injection, and study quality was low.
This article sets out what the pooled data found, what they failed to measure, how the oral evidence compares, and why nobody with kidney disease should act on this without their nephrologist.
Quick Answer: Is Astragalus Good for Kidneys?
The pooled evidence is promising and weak. Across 22 studies in 1323 people, proteinuria fell 0.53 g per 24 hours, albumin rose 3.55 g/L and haemoglobin rose 9.51 g/L, but time to dialysis and mortality were not reported in a single study. Most of the larger dataset used intravenous astragalus, not capsules.
Key Takeaways
- The Cochrane review pooled 22 separate studies covering 1323 participants.
- Proteinuria fell 0.53 g per 24 hours across 10 of them.
- Time to dialysis was reported in 0 of the 22 studies.
- In the 66-study diabetic review, only 4 trials used oral astragalus.
- A 2024 oral trial used 15 g of raw-herb equivalent daily.
Related Products
Why Kidneys at All?
Astragalus is 1 of the most widely used herbs in Chinese medicine for kidney complaints, which is why Chinese hospitals have run so many trials on it. That history explains both the volume of research and its methodological weaknesses.
- Traditional indication: Oedema, fatigue and protein loss.
- Modern trials: Mostly adjunctive, added to conventional care.
- Common outcomes: Proteinuria, creatinine, albumin, haemoglobin.
- Rarely measured: Dialysis, transplant and mortality.
The wider context on the root sits in the huang qi basics.
What the Cochrane Review Found
The 2014 Cochrane review is the single most useful document on this question. It pooled 22 studies with 1323 participants, 241 of whom were receiving dialysis, and reported several marker improvements alongside a blunt assessment of quality.[1]Astragalus (a traditional Chinese medicine) for treating chronic kidney disease — Cochrane Database of Systematic Reviews View source
| Outcome | Result | Evidence behind it |
|---|---|---|
| 24-hour proteinuria | -0.53 g | 10 studies, 640 participants |
| Serum creatinine | -21.39 micromol/L | 13 studies, 775 participants |
| Creatinine clearance | +5.75 mL/min | 4 studies, 306 participants |
| Haemoglobin | +9.51 g/L | 4 studies, 222 participants |
| Serum albumin | +3.55 g/L | 9 studies, 522 participants |
| Time to dialysis, mortality | Not reported | 0 studies |
Six of the 22 studies were judged high risk of bias and the other 16 unclear. The reviewers' own conclusion was that definitive conclusions could not be made.
The Injection Problem
This is the point that changes what a capsule buyer should expect. A 2019 systematic review of diabetic kidney disease pooled 66 studies in 4785 participants, and the impressive numbers came overwhelmingly from intravenous astragalus.[2]Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis — Journal of Ethnopharmacology View source
| Route | Trials | Participants |
|---|---|---|
| Injection, albuminuria | 32 RCTs | 2253 |
| Injection, proteinuria | 26 RCTs | 1812 |
| Injection, serum creatinine | 32 RCTs | 2880 |
| ORAL preparations, albuminuria | 4 RCTs | 236 |
An intravenous hospital preparation and a capsule taken at home are not the same intervention. Any page quoting the first while selling the second is skipping the most important line in the methods.
The Dose Nobody Mentions
A 2024 multi-centre randomized trial in Hong Kong tested oral astragalus granules added to standard care in 118 patients with diabetic chronic kidney disease, over 48 weeks.[3]Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial — Phytomedicine View source
- Population: eGFR 30 to 90, urine albumin-to-creatinine 300 to 5000 mg/g.
- Dose: Granules equivalent to 15 grams of raw herb daily.
- Duration: 48 weeks, with assessors blinded.
- Arithmetic: 15 grams is 15 capsules of 1000 mg.
That last line is the honest reality check. Taking 1 or 2 capsules of astragalus root is not the same intervention as a supervised 15-gram granule protocol, and pretending otherwise helps nobody.
If You Have Kidney Disease
Chronic kidney disease is a monitored condition with medications, targets and a care team. The trials all added astragalus to that care rather than replacing any part of it.
Before adding astragalus to a kidney care plan
- Tell your nephrologist or GP that you are considering it
- Ask specifically about interactions with your current medication
- Never reduce or stop a prescribed medicine to try a herb
- Keep your usual blood and urine monitoring schedule
- Stop and report anything unexpected, including swelling or reduced urine output
- Remember the trials measured markers, not dialysis or survival
The point of that list is not caution theatre. It is that the outcomes people actually care about were never measured, so a clinician tracking real numbers is the only sensible referee.
What Would Change the Picture
The research gap here is specific rather than vague, and naming it makes the current evidence easier to weigh.
- Oral trials at scale: More than the current 4 studies and 236 people.
- Hard outcomes: Dialysis, transplant and mortality, not just markers.
- Longer follow-up: Beyond the 48 weeks of the largest oral trial.
- Better reporting: The 22 pooled studies were low quality throughout.
Until those exist, the fair description is an adjunct with promising marker data and unproven clinical benefit. How that translates into a daily amount is covered in our dosage page.
Frequently Asked Questions
Is astragalus good for kidneys? +
The pooled evidence is promising but weak. Across 22 studies in 1323 participants, proteinuria fell 0.53 g per 24 hours and albumin rose 3.55 g/L, while time to dialysis and mortality were not reported in any of those 22 studies.
What does astragalus do to the kidneys? +
In trials it reduced protein loss in urine and raised haemoglobin and albumin when added to conventional therapy. Serum creatinine fell by 21.39 micromol/L across 13 studies, though heterogeneity was high at 70 percent.
Is capsule astragalus as good as the injection used in studies? +
There is no evidence that it is. In a 66-study review of diabetic kidney disease, 32 trials used injection for albuminuria while only 4 used oral preparations, covering 236 people. Capsule evidence is much thinner.
How much astragalus is used in kidney trials? +
The 2024 Hong Kong trial used oral granules equivalent to 15 grams of raw herb daily for 48 weeks, in 118 supervised patients. That is roughly 15 capsules of 1000 mg, which is far above typical supplement labels.
Can astragalus reverse kidney disease? +
Not 1 trial supports that. All 22 pooled studies added astragalus to standard care and measured markers such as proteinuria, not disease reversal, and Cochrane reviewers concluded that definitive conclusions could not be made.
Is astragalus safe for people with kidney disease? +
Reported adverse events were similar to control groups, and 6 of the 22 Cochrane studies explicitly reported none. Even so, kidney disease is monitored care, so this is a conversation for your nephrologist before you start.
Does astragalus help with proteinuria? +
That is its most consistent finding: a 0.53 g reduction in 24-hour proteinuria across 10 studies with 640 participants, and similar direction in the diabetic kidney disease reviews. Heterogeneity was high at 90 percent, so precision is limited.
Can I take astragalus with my blood pressure medication? +
Ask first. Two small studies with 77 participants reported systolic pressure falling 16.65 mmHg, so the combination is worth monitoring rather than assuming. Never adjust prescribed doses on your own.
Does astragalus help dialysis patients? +
Of the 1323 participants in the Cochrane review, 241 were on dialysis, and haemoglobin rose 11.20 g/L in that subgroup across 3 studies. It remains adjunctive, low-quality evidence rather than standard care.
How long would I need to take it? +
Trials ran from 8 weeks to 48 weeks, with the largest oral study using the full year-long timeframe. Nothing here supports a 2-week trial, and monitoring should continue throughout whatever period you and your clinician agree.
Is astragalus better than milk thistle for organ support? +
They target different organs and different evidence bases: astragalus has kidney trials, milk thistle has liver research. Neither replaces treatment, and using both because 2 organs exist is not a strategy.
Related Reading
- All 4 Benefit Claims, Graded
- The Immune Side of the Root
- Safety, Interactions and Cautions
- Why It Is Not an Adaptogen Like Ashwagandha
Related Products
